Drugs

The USPS announced it is temporarily suspending inbound packages from China and Hong Kong Posts.

The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so that physicians would prescribe a specific migraine drug to patients.

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.

A Justice Department lawsuit alleges the illegal prescription-filling by Walgreens included opioids, and began in August 2012.

The DOJ has filed a lawsuit against CVS Health, accusing the drugstore giant of filling prescriptions for controlled substances that “lacked a legitimate medical purpose."

Mexican President Claudia Sheinbaum has clapped back at President-elect Trump’s proposed 25% tariff on imported goods from Mexico, saying she would impose tariffs of her own on the U.S.

President-elect Trump on Monday said he would issue an executive order upon taking office to charge Mexico and Canada a 25% tariff on all products coming into the U.S.

Voters in the state of California will have the opportunity to roll back a decade-old criminal justice reform measure and toughen punishments for theft and drug crimes in the state.

The growth of highly sought-after weight-loss drugs like Wegovy and Ozempic, otherwise known as GLP-1 medications, represents a shift in obesity management.

A new study found that weekly injections of 2.4 mg of semaglutide could lower the risk of deaths related to COVID-19, marking another potential benefit of these blockbuster drugs.

Pfizer announced that it is advancing its oral weight-loss treatment, called danuglipron, to the next round in an ongoing study after seeing "encouraging" results.

The FDA has officially begun to recall Diamond Shruumz products, weeks after it initially reported the "microdosing" products were linked to various illnesses.